Brixtel Defense Plans Dawson County, Montana, Operations
01/12/2024
The new facility will produce primers, a key component in most ammunition. The company is partnering with Alpha Loading Systems.
“In an era where outsourcing is commonplace, we choose to invest in the heart of our nation. We are proud to announce a $125 million investment in Montana,” said Andy Mansoor, CEO of Brixtel Defense. “This expansion is a testament to our belief in the American workforce, the American dream, and the fundamental values upon which this great country was built. As we embark on this journey in Glendive, we are reminded of our purpose. Together, we build more than ammunition; we forge the future of freedom.”
Brixtel Defense manufactures munitions and propellants for the U.S. Armed Forces and its allies.
“Montana is proudly home to over 150 innovative firearms and ammunitions businesses, the highest per capita in the country,” Governor Greg Gianforte noted. “We’re thrilled to welcome Brixtel Defense to Big Sky Country, and appreciate the ammunition leader’s investment in our state and people.”
Project Announcements
Poland-Based JGB Brothers Plans Bamberg County, South Carolina, Production Operations
01/23/2026
Electric Research and Manufacturing Cooperative Plans Waddell, Arizona, Transformer Production Operations
01/23/2026
Viking Attachments Expands Morgan City, Louisiana, Manufacturing Operations
01/23/2026
France-Based Reju Plans Rochester, New York, Textile Regeneration Operations
01/23/2026
Heil Trailer International Expands Athens, Tennessee, Manufacturing Operations
01/23/2026
Ampirical Expands Covington, Louisiana, Operations
01/23/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025